4//SEC Filing
Boissel Stephane 4
Accession 0001209191-20-013229
CIK 0001001233other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:31 PM ET
Size
10.3 KB
Accession
0001209191-20-013229
Insider Transaction Report
Form 4
Boissel Stephane
EVP, Corporate Strategy
Transactions
- Award
Common Stock
2020-02-25+55,000→ 70,116 total - Tax Payment
Common Stock
2020-02-25$6.80/sh−2,384$16,211→ 15,116 total - Award
Stock Option (Right-to-Buy)
2020-02-25+110,000→ 110,000 totalExercise: $6.80Exp: 2030-02-24→ Common Stock (110,000 underlying)
Footnotes (4)
- [F1]Represents shares underlying the portion of the restricted stock unit grant that vested on February 25, 2020 surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on February 25, 2020 of $6.80/share, pursuant to the terms of the Issuer's 2018 Equity Incentive Plan.
- [F2]Includes 3,449 shares resulting from the February 25, 2020 vesting of Reporting Person's February 25, 2019 restricted stock unit grant and 11,667 shares subject to such restricted stock unit grant that will vest in two remaining annual installments on February 25, 2021 and February 25, 2022, resulting in such restricted stock unit grant being vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates.
- [F3]Represents 55,000 shares subject to restricted stock units granted on February 25, 2020 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates.
- [F4]One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2020 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such vesting date.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001755198
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:31 PM ET
- Size
- 10.3 KB